Introduction

This page provides a comprehensive analysis of the known insider trading history of Douglas B Given. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Douglas B Given has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ARWR / Arrowhead Pharmaceuticals, Inc. Director 124,167
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Douglas B Given. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Douglas B Given as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2024-12-18 2024-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -547 124,167 -0.44 22.04 -12,056 2,736,641
2024-12-18 2024-12-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -5,000 124,714 -3.85 21.90 -109,500 2,731,237
2024-01-16 2024-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,100 129,711 -0.84 38.55 -42,405 5,000,359
2024-01-16 2024-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,811 130,811 -1.37 37.76 -68,383 4,939,423
2023-12-19 2023-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 14,987 132,622 12.74 25.41 380,820 3,369,925
2023-05-08 2023-05-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -6,500 117,635 -5.24 40.90 -265,850 4,811,272
2023-03-01 2023-02-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -875 13,000 -6.31 32.62 -28,542 424,060
2023-01-11 2023-01-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 7,867 124,135 6.77
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 6,400 116,268 5.83
2021-12-29 2021-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 655 109,868 0.60 66.37 43,472 7,291,939
2021-12-29 2021-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -655 109,213 -0.60
2021-09-10 2021-09-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -5,000 109,868 -4.35 65.24 -326,200 7,167,788
2021-06-24 2021-06-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -4,500 114,868 -3.77 89.21 -401,445 10,247,374
2021-02-24 2021-02-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,125 13,875 -7.50 88.73 -99,821 1,231,129
2021-01-19 2021-01-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -3,000 12,500 -19.35 83.28 -249,840 1,041,000
2021-01-05 2021-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -4,000 119,368 -3.24 76.08 -304,320 9,081,517
2021-01-05 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 9,500 123,368 8.34
2020-12-29 2020-12-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -35 113,868 -0.03
2020-12-29 2020-12-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -35 113,903 -0.03
2020-12-29 2020-12-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -200 113,938 -0.18
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -35 114,138 -0.03
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -35 114,138 -0.03
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -200 114,208 -0.17
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -200 114,208 -0.17
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -65 114,608 -0.06
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -65 114,608 -0.06
2020-12-18 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -500 15,000 -3.23 79.59 -39,795 1,193,850
2020-12-18 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -9,075 114,738 -7.33 79.30 -719,648 9,098,723
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift 15,500 15,500
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift 15,500 15,500
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -31,000 123,813 -20.02
2020-04-16 2020-04-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -1,112 154,813 -0.71
2020-04-16 2020-04-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -25,000 155,925 -13.82 36.89 -922,250 5,752,073
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 8,000 180,925 4.63
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -7,000 0 -100.00
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,000 7,000 -58.82
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -18,000 17,000 -51.43
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -30,000 35,000 -46.15
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -65,000 175,130 -27.07 19.25 -1,251,250 3,371,252
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 7,000 240,130 3.00 4.75 33,250 1,140,618
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,000 233,130 4.48 2.62 26,200 610,801
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 18,000 223,130 8.77 2.19 39,420 488,655
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 30,000 205,130 17.13 5.19 155,700 1,064,625
2019-02-26 2019-02-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,000 175,130 -1.68 18.05 -54,150 3,161,096
2019-01-24 2019-01-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,000 178,130 -1.66 13.58 -40,740 2,419,005
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 36,000 181,130 24.81
2018-12-28 2018-12-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,000 145,130 -2.03 12.00 -36,000 1,741,560
2018-11-26 2018-11-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,000 148,130 -1.99 12.74 -38,220 1,887,176
2018-10-23 2018-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -3,870 151,130 -2.50
2018-04-25 2018-04-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -25,000 155,000 -13.89 6.63 -165,750 1,027,650
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 30,000 180,000 20.00
2017-01-04 2017-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 80,000 150,000 114.29
2016-10-18 2016-10-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -12,000 70,000 -14.63 6.72 -80,640 470,400
2016-10-18 2016-01-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		G - Gift -8,000 82,000 -8.89
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 35,000 90,000 63.64
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 35,000 55,000 175.00
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy) 		M - Exercise -2,000 65,000 -2.99
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		S - Sale X -2,000 20,000 -9.09 15.24 -30,480 304,800
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		M - Exercise 2,000 22,000 10.00 2.19 4,380 48,180
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy) 		M - Exercise -5,000 67,000 -6.94
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		S - Sale -5,000 20,000 -20.00 13.90 -69,500 278,002
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		M - Exercise 5,000 25,000 25.00 2.01 10,050 50,250
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 20,000 20,000
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 7,000 72,000 10.77
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 5,000 65,000 8.33
2013-04-01 2013-03-21 4/A ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 20,000 60,000 50.00
2013-03-25 2013-03-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award -20,000 60,000 -25.00
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award -10,000 40,000 -20.00
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)